Arzu Altunçekiç Yıldırım

Risk of hepatitis B reactivation in COVID-19 patients receiving corticosteroid therapy

COVID-19 and HBV are significant public health issues, and managing their co-infection remains unclear. Corticosteroid therapy improves survival in severe COVID-19 but may increase the risk of HBV reactivation (HBVr). Evidence regarding the incidence and outcomes of HBVr in COVID...